Price $47.74 |
Market Cap
5.64B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
7.79
|
P/S
12.18
|
Dividend %
-
|
|
P/CF
62.1
|
P/FCF
-
|
Op. Cash Flow
1.5K
|
FCF
-0.2
|
|
Op. Margin
-3.50%
|
Net Margin
0.90%
|
ROE
0.70%
|
ROI
0.30%
|
|
ROA
0.50%
|
EPS Growth
-58.50%
|
Current Ratio
6.1
|
Debt/Equity
24.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AEterna Zentaris Inc. (USA) (AEZS) | $0.85 | - | - | 133.3M | Strong Buy |
| RadNet Inc. (RDNT) | $22.11 | - | - | 1.14B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $23.54 | - | - | 888.4M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $66.08 | - | 3.10% | 141.03B | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
